Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade.

ABSTRACT:

SUBMITTER: Merryman RW 

PROVIDER: S-EPMC12721160 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature